Immunity Pharma Ltd.

Our drugs activate self-healing processes in neurologic diseases. Our lead drug IPL344 had unparalleled clinical results in an open label phase 2 study in ALS.

  • Stage Full Product Ready
  • Industry Biotechnology
  • Location Mevaseret Zion, Israel
  • Currency USD
  • Founded March 2007
  • Employees 3
  • Incorporation Type Other
  • Website immunitypharma.com

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free